Knowledge Center

Patent / Jan 01, 1976

Alkali methal polymetaphate complexes of doxycycline

Authors:
  • Ivan Villax
Source:
GB 1463726

Alkali metal polymetaphosphate complexes of doxycycline (I) were prepd. to increase I blood levels and counteract pharmacol. disadvantages due to chelation of tetracyclines. Thus, metaphosphoric acid in CHCl3 and MeOH was treated with I to give a soln. which was treated with NaOH in MeOH. After washup I polyphosphate mono-Na complex (II) [56648-96-5], m. 184-8.degree., was obtained. Administration of II gave an av. overall increase of nearly 50% serum levels compared to I hyclate.

Also in the Knowledge Center

Related Content

HPAPI – Highly Potent API

Our service for HPAPIs ranges from Drug Substance to Particle Engineering.

Page
Read more

Areas of Expertise

ËÄÉ«AV analytical chemists master several areas of knowledge

Page
Read more

¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð®

Make your drug soluble with ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® technology. ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more